Protagenic Therapeutics Strategic Asset Allocation Index
Protagenic Therapeutics strategic asset allocation index. Protagenic Therapeutics (PTIX) has a Strategic Asset Allocation Index of 0.2% as of September 2018. Strategic assets (PP&E of $732.00 plus long-term investments of $0.00) total $732.00, measured against net assets of $323.03K. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See Protagenic Therapeutics (PTIX) net asset quality to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Strategic Asset Allocation Index of Protagenic Therapeutics (2016–2017)
Strategic asset allocation index of Protagenic Therapeutics from 2016 to 2017. This chart shows how Protagenic Therapeutics's Strategic Asset Allocation Index has evolved across 2 annual periods from 2016 to 2017. As of September 2018, the index stands at 0.2%, representing strategic assets of $732.00 against net assets of $323.03K USD. Check Protagenic Therapeutics tangible book value ratio to evaluate the tangible quality of the company's equity base.
Protagenic Therapeutics Strategic Asset Allocation Index by Year (2016–2017)
Protagenic Therapeutics strategic asset allocation index by year from 2016 to 2017. The table below presents the year-by-year Strategic Asset Allocation Index for Protagenic Therapeutics from 2016 to 2017, covering 2 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see Protagenic Therapeutics stock valuation.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2017 | 0.1% | $1.02K | $1.02K | $0.00 | $1.22 Million | ▲ +0.0 pp |
| 2016 | 0.0% | $1.10K | $1.10K | $0.00 | $2.48 Million | — |